

Odomzo 200mg Capsule (Sonidegib)
Manufactured By
Novartis
Pack Of
30
Salt Composition
Sonidegib
Storage
Keep in cold place
Overview
Odomzo 200mg Capsule is an anticancer medicine with Sonidegib as an active ingredient. It is prescribed to treat locally advanced basal cell carcinoma (a type of skin cancer) in adults. It is commonly used when cancer can't be treated either by surgery or by radiotherapy. It works by interfering with the pathways that promote abnormal cell multiplication to slow down the progression of cancer. Take it in a exact dose as advice by the doctor.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | odomzo |
| Generic / Active Ingredient | Odomzo |
| Strength | 200 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | novartis |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Skin Cancer |
Uses and Indications
Skin Cancer
Side Effects of Odomzo 200mg Capsule
Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Odomzo 200mg Capsule(Sonidegib 200mg) also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include:
● Muscle spasms
● Alopecia
● Dysgeusia
● Fatigue
● Nausea
● Musculoskeletal pain
● Diarrhea
● Decreased weight
● Decreased appetite
● Myalgia
● Abdominal pain
● Headache
● Pain
● Vomiting
● Pruritus
Seek medical attention in case of any unusual or severe side effects immediately.
Odomzo 200mg Capsule Dosage and How To Take It
The dosage and duration of the Odomzo 200mg Capsule(Sonidegib 200mg) are decided by the doctor based on the stage of cancer and other health factors. Take this tablet on an empty stomach for better results. Before starting this medicine, please inform your doctor about your medical history. If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.
Safety Advice for Odomzo 200mg Capsule
- ● Alcohol: Avoid the consumption of alcohol while taking Odomzo 200mg Capsule(Sonidegib 200mg), as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
- ● Pregnancy: Do not take Odomzo 200mg Capsule without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.
- ● Breastfeeding: Breastfeeding women should discuss the potential risks and benefits of the Odomzo 200mg Capsule(Sonidegib 200mg) with their healthcare provider before starting treatment.
- ● Driving: Odomzo 200mg Capsule may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Share your medical history with the doctor before starting the treatment with Odomzo 200mg Capsule(Sonidegib 200mg). Do not take it without consulting a doctor if you have any kidney related issue.
- ● Liver: Share your medical history with the doctor before starting the treatment with Odomzo 200mg Capsule(Sonidegib). Do not take it without consulting a doctor if you have any liver related issue.
FAQs About Odomzo 200mg Capsule
Is Odomzo 200mg Capsule cytotoxic(Sonidegib)?
As per some research studies Odomzo 200mg Capsule may have some level of cytotoxic effects in vitro. However, there is still no solid evidence to show that this is the case.
What is Odomzo 200mg Capsule used for?
Odomzo 200mg Capsule(Sonidegib 200mg) is prescribed to treat locally advanced basal cell carcinoma (a rare type of skin cancer) in adults.
How does Odomzo 200mg Capsule work?
Odomzo is a medication that works by inhibiting the action of a specific protein, known as smoothened (SMO). By blocking the action of SMO with Odomzo, abnormal cell growth can be stopped.
Can odomozo be taken with meals?
Odomzo 200mg Capsule(Sonidegib 200mg) should be taken 1 hr before meals or two hours after meals but is generally preferred on an empty stomach.
What if I can't tolerate the side effects after taking Odomzo 200mg(Sonidegib 200mg)?
In that case it is essential to discuss it with the doctor immediately to avoid facing further complications or side effects associated with this medicine.
References
● Burness, C. B., & Scott, L. J. (2016). Sonidegib: a review in locally advanced basal cell carcinoma. Targeted oncology, 11(2), 239-246.
● Dummer, R., Ascierto, P. A., Basset‐Seguin, N., Dréno, B., Garbe, C., Gutzmer, R., ... & Grob, J. J. (2020). Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion. Journal of the European Academy of Dermatology and Venereology, 34(9), 1944-1956.
● Casey, D., Demko, S., Shord, S., Zhao, H., Chen, H., He, K., ... & Pazdur, R. (2017). FDA approval summary: sonidegib for locally advanced basal cell carcinoma. Clinical Cancer Research, 23(10), 2377-2381.
● Burness, C. B. (2015). Sonidegib: first global approval. Drugs, 75(13), 1559-1566.
● Jain, S., Song, R., & Xie, J. (2017). Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. OncoTargets and therapy, 1645-1653.
Marketer Details
Novartis
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


